Fulvestrant | USP | Pharmacopoeia | Reference Standards | PharmaCompass.com

Please Wait

Applying Filters...

Fulvestrant

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 13 USDMF, 9 CEP/COS, 2 JDMF, 2 EU WC, 12 NDC API, 24 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

97 Drugs in Development

97 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

62 FDF Dossiers, 19 FDA Orange Book, 13 Europe, 6 Canada, 4 Australia, 5 South Africa, 15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAMUSCULAR - 125MG/2.5ML (50MG/ML), SOLUTION;INTRAMUSCULAR - 250MG/5ML (50MG/ML)

RELATED EXCIPIENT COMPANIES

2 Nanjing Well Pharmaceutical, 1 Actylis, 2 Finar, 1 TopChem Pharmaceuticals

EXCIPIENTS BY APPLICATIONS

3 Topical, 3 Parenteral, 1 Solubilizers

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 101 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 11 Finished Drug Prices, 10 Annual Reports

MARKET PLACE

6 APIs, 8 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 4 Others

$ Xls

Filters

Filters

FILTER :

filter Catalog Number Reset all filters

2 All

01 11286650

02 11286661

filter Description Reset all filters

filter CAS Number Reset all filters

Product Main Page

01

USP

The Generic Rx Session

Not Confirmed

02

USP

The Generic Rx Session

Not Confirmed

Contact us
to update this info